You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CARISOPRODOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Carisoprodol, and when can generic versions of Carisoprodol launch?

Carisoprodol is a drug marketed by Able, Accelrx Labs, Allied, Aurobindo Pharma, Chartwell Rx, Epic Pharma Llc, Hikma Intl Pharms, Natco, Nostrum Labs Inc, Novast Labs, Orient Pharma Co Ltd, Oxford Pharms, Pioneer Pharms, Sandoz, Sciegen Pharms Inc, Strides Pharma, Sun Pharm Inds Ltd, Sun Pharm Industries, Wanbang Biopharms, Watson Labs, Watson Labs Teva, Genus, and Ingenus Pharms Nj. and is included in thirty-two NDAs.

The generic ingredient in CARISOPRODOL is aspirin; carisoprodol; codeine phosphate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; carisoprodol; codeine phosphate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CARISOPRODOL?
  • What are the global sales for CARISOPRODOL?
  • What is Average Wholesale Price for CARISOPRODOL?
Summary for CARISOPRODOL
Drug patent expirations by year for CARISOPRODOL
Drug Prices for CARISOPRODOL

See drug prices for CARISOPRODOL

Drug Sales Revenue Trends for CARISOPRODOL

See drug sales revenues for CARISOPRODOL

Recent Clinical Trials for CARISOPRODOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ache Laboratorios Farmaceuticos S.A.Phase 3
Pharmagenix Projetos em Medicina FarmacĂȘutica Ltda.Phase 3
Farmoquimica S.A.Phase 3

See all CARISOPRODOL clinical trials

Pharmacology for CARISOPRODOL
Medical Subject Heading (MeSH) Categories for CARISOPRODOL

US Patents and Regulatory Information for CARISOPRODOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oxford Pharms CARISOPRODOL AND ASPIRIN aspirin; carisoprodol TABLET;ORAL 040252-001 Dec 10, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs Teva CARISOPRODOL carisoprodol TABLET;ORAL 086179-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs CARISOPRODOL COMPOUND aspirin; carisoprodol TABLET;ORAL 088809-001 Oct 3, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx CARISOPRODOL AND ASPIRIN aspirin; carisoprodol TABLET;ORAL 089594-001 Mar 31, 1989 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Able CARISOPRODOL carisoprodol TABLET;ORAL 040421-001 Jun 21, 2001 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz CARISOPRODOL carisoprodol TABLET;ORAL 089566-001 Aug 30, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.